Nano Pharmaceuticals

Parmax Pharma Ltd.

PARMAX

Market Cap
₹32 Cr.
P/E
0.00

Parmax Pharma Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
32.00 Cr
PE
PE
-
Prom Holding
Prom Holding
30.80 %
ROE (%)
ROE (%)
105
ROCE (%)
ROCE (%)
-13.36
Div Yield (%)
Div Yield (%)
-
Sales
Sales
12.11 Cr
OPM (%)
OPM (%)
-29.61 %
Debt to Equity
Debt to Equity
-4.07
Institutions
Institutions
-
Individual < 2 lac
Individual < 2 lac
34.58 %
No. of Shareholders
No. of Shareholders
2,388
View more
Edit Ratio's

About

Parmax Pharma Limited is a pharmaceutical company specializing in active pharmaceutical ingred… Read more
Low
23
52W Range
High
85
  • Parmax Pharma
  • Panjon
  • Medicamen Organics

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Parmax Pharma Ltd. Business

Parmax Pharma Limited excels in producing active pharmaceutical ingredients (API) and providing Contract Manufacturing Operations (CMO) with a strong emphasis on quality by design methods in compliance with cGMP standards.

Parmax Pharma major competitors are Panjon, Medicamen Organics, Walpar Nutritions, Chandra Bhagat Pharm, JFL Life Sciences, Deccan Health Care, Medistep Healthcare.
Market Cap of Parmax Pharma is ₹31 Crs.
While the median market cap of its peers are ₹31 Crs.

Parmax Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Parmax Pharma is -0.36 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material